ProPhase Labs, Inc.

OTCPK:PRPH Stock Report

Market Cap: US$1.1m

ProPhase Labs Management

Management criteria checks 2/4

ProPhase Labs' CEO is Ted Karkus, appointed in Jun 2009, has a tenure of 17.08 years. directly owns 2.29% of the company’s shares, worth $24.47K. The average tenure of the management team and the board of directors is 2.5 years and 1.1 years respectively.

Key information

Ted Karkus

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure17.1yrs
CEO ownership2.3%
Management average tenure2.5yrs
Board average tenure1.1yrs

Recent management updates

Recent updates

Analysis Article • Nov 09

Investors Give ProPhase Labs, Inc. (NASDAQ:PRPH) Shares A 65% Hiding

ProPhase Labs, Inc. ( NASDAQ:PRPH ) shareholders that were waiting for something to happen have been dealt a blow with...
Analysis Article • Nov 09

It's Down 65% But ProPhase Labs, Inc. (NASDAQ:PRPH) Could Be Riskier Than It Looks

ProPhase Labs, Inc. ( NASDAQ:PRPH ) shareholders that were waiting for something to happen have been dealt a blow with...
Analysis Article • Jul 03

Market Cool On ProPhase Labs, Inc.'s (NASDAQ:PRPH) Revenues Pushing Shares 26% Lower

Unfortunately for some shareholders, the ProPhase Labs, Inc. ( NASDAQ:PRPH ) share price has dived 26% in the last...
Analysis Article • Mar 04

Does This Valuation Of ProPhase Labs, Inc. (NASDAQ:PRPH) Imply Investors Are Overpaying?

Key Insights The projected fair value for ProPhase Labs is US$3.46 based on Dividend Discount Model ProPhase Labs...
Analysis Article • Jan 09

ProPhase Labs, Inc.'s (NASDAQ:PRPH) Business And Shares Still Trailing The Industry

You may think that with a price-to-sales (or "P/S") ratio of 1.5x ProPhase Labs, Inc. ( NASDAQ:PRPH ) is a stock worth...
Analysis Article • Sep 21

ProPhase Labs, Inc. (NASDAQ:PRPH) Shares Could Be 28% Above Their Intrinsic Value Estimate

Key Insights ProPhase Labs' estimated fair value is US$3.39 based on Dividend Discount Model Current share price of...
Analysis Article • Aug 11

Here's Why ProPhase Labs (NASDAQ:PRPH) Can Afford Some Debt

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' When we think about how risky a company...
Analysis Article • Apr 07

We Ran A Stock Scan For Earnings Growth And ProPhase Labs (NASDAQ:PRPH) Passed With Ease

It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...
Analysis Article • Jan 24

ProPhase Labs (NASDAQ:PRPH) Seems To Use Debt Quite Sensibly

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...

CEO Compensation Analysis

How has Ted Karkus's remuneration changed compared to ProPhase Labs's earnings?
DateTotal CompensationSalaryCompany Earnings
Mar 31 2026n/an/a

-US$24m

Dec 31 2025n/an/a

-US$23m

Sep 30 2025n/an/a

-US$50m

Jun 30 2025n/an/a

-US$48m

Mar 31 2025n/an/a

-US$49m

Dec 31 2024US$2mUS$675k

-US$50m

Sep 30 2024n/an/a

-US$24m

Jun 30 2024n/an/a

-US$24m

Mar 31 2024n/an/a

-US$22m

Dec 31 2023US$3mUS$675k

-US$16m

Sep 30 2023n/an/a

-US$10m

Jun 30 2023n/an/a

-US$4m

Mar 31 2023n/an/a

US$7m

Dec 31 2022US$902kUS$675k

US$18m

Sep 30 2022n/an/a

US$31m

Jun 30 2022n/an/a

US$27m

Mar 31 2022n/an/a

US$18m

Dec 31 2021US$941kUS$590k

US$6m

Sep 30 2021n/an/a

-US$5m

Jun 30 2021n/an/a

-US$2m

Mar 31 2021n/an/a

-US$460k

Dec 31 2020US$445kUS$125k

-US$2m

Sep 30 2020n/an/a

-US$2m

Jun 30 2020n/an/a

-US$2m

Mar 31 2020n/an/a

-US$3m

Dec 31 2019US$249kUS$125k

-US$3m

Compensation vs Market: Insufficient data to establish whether Ted's total compensation is reasonable compared to companies of similar size in the US market.

Compensation vs Earnings: Ted's compensation has been consistent with company performance over the past year.

CEO

Ted Karkus (67 yo)

17.1yrs
Tenure
US$2,123,200
Compensation

Mr. Ted William Karkus has served as the Chief Executive Officer of ProPhase Labs, Inc. since June 2009. Mr. Karkus founded 2001 Forrester Financial LLC and served as its Managing Member. He is a Managemen...

Leadership Team

NamePositionTenureCompensationOwnership
Ted Karkus
Chairman & CEO17.1yrsUS$2.12m2.29%
$ 24.5k
Jason Karkus
President of Nebula Genomics2.5yrsno datano data
Kevin Quinn
Chief Product Officer of Nebula Genomicsless than a yearno datano data
2.5yrs
Average Tenure

Experienced Management: PRPH's management team is considered experienced (2.5 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Ted Karkus
Chairman & CEO17.1yrsUS$2.12m2.29%
$ 24.5k
James McCullough
Member of Clinical Science Advisory Board1.1yrsno datano data
Louis Gleckel
Independent Director17.1yrsUS$189.25k0.074%
$ 790.3
Carolina Abenante
Independent Director1.1yrsno datano data
Joe Abdo
Member of Clinical Science Advisory Board1.1yrsno datano data
1.1yrs
Average Tenure
62.5yo
Average Age

Experienced Board: PRPH's board of directors are not considered experienced ( 1.1 years average tenure), which suggests a new board.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/07/10 22:14
End of Day Share Price 2026/07/10 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

ProPhase Labs, Inc. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Hunter DiamondDiamond Equity Research LLC